Rabbit anti-KIAA0082 Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A300-304A maps to a region between residues 100 and 150 of human KIAA0082 using the numbering given in TrEMBL entry Q8N1G2 (GeneID 23070).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to KIAA0082 immobilized on solid support.
The epitope recognized by A300-304A-T maps to a region between residues 100 and 150 of human KIAA0082 using the numbering given in TrEMBL entry Q8N1G2 (GeneID 23070).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4.
Additional Product Information
KIAA0082 was first identified as a hypothetical protein predicted from the in silico analysis of long cDNAs isolated in the Kazusa cDNA sequencing project. KIAA0082 contains a G-patch and WW domain and several predicted phosphoserine sites.
Alternate Names
Cap methyltransferase 1; cap1 2'O-ribose methyltransferase 1; cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1; FtsJ methyltransferase domain containing 2; ftsJ methyltransferase domain-containing protein 2; FTSJD2; hMTr1; interferon-stimulated gene 95 kDa protein; ISG95; KIAA0082; MTr1; S-adenosyl-L-methionine-dependent methyltransferase FTSJD2
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of cell lysates are performed using Goat anti-Rabbit IgG Heavy and Light Chain Antibody (Cat. No. A120-101P).
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.